BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02030834-completion@plaintrial.com
DTSTAMP:20260928T035300Z
DTSTART;VALUE=DATE:20200901
SUMMARY:Phase IIa Study of Redirected Autologous T Cells Engineered to Cont
 ain Anti-CD19 Attached to TCRz and 4-Signaling Domains in Patients With Ch
 emotherapy Relapsed or Refractory CD19+ Lymphomas — estimated completion
  date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT02030834
URL:https://plaintrial.com/trial/NCT02030834
END:VEVENT
END:VCALENDAR